PARP1 and infection: Primary peripheral blood mononuclear cells (PBMCs) were incubated with EBV at a low or high multiplicity of infection (MOI) with or without either olaparib or BMN673, a more potent PARP inhibitor, and observed by light microscopy to assess the outgrowth of LCLs (Fig. 7A).